Assessing interactions between mdm-2, p53, and bcl-2 as prognostic variables in muscle-invasive bladder cancer treated with neo-adjuvant chemotherapy followed by locoregional surgical treatment

Identifying changes in the tumor micro-environment in muscle-invasive bladder cancer after neo-adjuvant chemotherapy

European Urology Open Science ◽

10.1016/s2666-1683(20)32681-1 ◽

2020 ◽

Vol 19 ◽

pp. e199

Author(s):

J. van Dorp ◽

A. Gil Jimenez ◽

C.S. Voskuilen ◽

B.W.G. Van Rhijn ◽

M.S. Van Der Heijden

Keyword(s):

Bladder Cancer ◽

Adjuvant Chemotherapy ◽

Invasive Bladder Cancer ◽

Neo-adjuvant chemotherapy in the treatment of muscle-invasive bladder cancer

Treatment and Management of Bladder Cancer ◽

10.3109/9780203091746-25 ◽

2008 ◽

pp. 221-228

Keyword(s):

Bladder Cancer ◽

Adjuvant Chemotherapy ◽

Invasive Bladder Cancer ◽

A study of split-dose cisplatin-based neo-adjuvant chemotherapy in muscle-invasive bladder cancer

Oncology Letters ◽

10.3892/ol.2012.563 ◽

2012 ◽

Cited By ~ 2

Author(s):

S. Hussain

Keyword(s):

Bladder Cancer ◽

Adjuvant Chemotherapy ◽

Invasive Bladder Cancer ◽

Split Dose ◽

1441 INCIDENCE, CHARACTERISTICS, AND IMPLICATIONS OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER UNDERGOING CISPLATIN BASED NEO-ADJUVANT CHEMOTHERAPY

The Journal of Urology ◽

10.1016/j.juro.2013.02.2795 ◽

2013 ◽

Vol 189 (4S) ◽

Cited By ~ 1

Author(s):

Laurel Patterson ◽

Rishikesh Pandya ◽

David Margel ◽

Sebastien J Hotte ◽

Bobby Shayegan ◽

...

Keyword(s):

Bladder Cancer ◽

Adjuvant Chemotherapy ◽

Invasive Bladder Cancer ◽

Thromboembolic Events ◽

Neo-adjuvant chemotherapy for muscle-invasive bladder cancer: a look ahead

Annals of Oncology ◽

10.1093/annonc/mdl008 ◽

2006 ◽

Vol 17 (9) ◽

pp. 1360-1369 ◽

Cited By ~ 8

Author(s):

R. Sawhney ◽

D. Bourgeois ◽

U.B. Chaudhary

Keyword(s):

Bladder Cancer ◽

Adjuvant Chemotherapy ◽

Invasive Bladder Cancer ◽

Look Ahead ◽

1147 Neutrophil-to-lymphocyte ratio as a predictor of response to neo-adjuvant chemotherapy in muscle-invasive bladder cancer

European Urology Supplements ◽

10.1016/s1569-9056(16)61148-x ◽

2016 ◽

Vol 15 (3) ◽

pp. e1147

Author(s):

K. Van Kessel ◽

L. De Haan ◽

E. Fransen Van De Putten ◽

B. Van Rhijn ◽

R. De Wit ◽

...

Keyword(s):

Bladder Cancer ◽

Adjuvant Chemotherapy ◽

Neutrophil To Lymphocyte Ratio ◽

Invasive Bladder Cancer ◽

Lymphocyte Ratio ◽

Timing of treatment for muscle-invasive bladder cancer in the neo-adjuvant chemotherapy era

AME Medical Journal ◽

10.21037/amj.2020.03.07 ◽

2020 ◽

Vol 5 ◽

pp. 37-37

Author(s):

Giovanni Motterle ◽

R. Jeffrey Karnes

Keyword(s):

Bladder Cancer ◽

Adjuvant Chemotherapy ◽

Invasive Bladder Cancer ◽

Timing Of Treatment ◽

PD06-10 PATIENT REFUSAL OF NEO-ADJUVANT CHEMOTHERAPY FOR MUSCLE INVASIVE BLADDER CANCER

The Journal of Urology ◽

10.1016/j.juro.2017.02.372 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

Pauline Filippou ◽

Allison Deal ◽

Benjamin McCormick ◽

Gopal Narang ◽

Matthew Nielsen ◽

...

Keyword(s):

Bladder Cancer ◽

Adjuvant Chemotherapy ◽

Invasive Bladder Cancer ◽

Patient Refusal ◽

EP-1120 NEO-ADJUVANT CHEMOTHERAPY AND CHEMORADIOTHERAPY WITH GEMCITABINE IN MUSCLE INVASIVE BLADDER CANCER

Radiotherapy and Oncology ◽

10.1016/s0167-8140(12)71453-6 ◽

2012 ◽

Vol 103 ◽

pp. S432

Author(s):

C. Thompson ◽

C. Anandadas ◽

B. Sanderson ◽

J. Lyons ◽

J. Stratford ◽

...

Keyword(s):

Bladder Cancer ◽

Adjuvant Chemotherapy ◽

Invasive Bladder Cancer ◽

789 Adjuvant chemotherapy after radical cystectomy for muscle-invasive bladder cancer: A comparative study using inverse-probability-of-treatment weighting (IPTW)

European Urology Supplements ◽

10.1016/s1569-9056(14)60777-6 ◽

2014 ◽

Vol 13 (1) ◽

pp. e789

Author(s):

T. Kwon ◽

I.G. Jeong ◽

D. You ◽

B. Lim ◽

K-S. Han ◽

...

Keyword(s):

Bladder Cancer ◽

Adjuvant Chemotherapy ◽

Comparative Study ◽

Radical Cystectomy ◽

Invasive Bladder Cancer ◽

Inverse Probability ◽